Metraipolis › archive › dc_22d5083452d1

Metabolic reprogramming and cisplatin resistance: the emerging role of Pyruvate Dehydrogenase Kinases (PDKs) — Europe PMC PMID:41904526

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41904526
DOI
10.1186/s12964-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-03T17:47:04.204Z
SHA-256 of the archived text
b0a05df1dee4c8d69fd83fba09cae8692ecc06fce8bd5324448890957b01e87f
Stable URL of this page
https://metraipolis.com/documento/dc_22d5083452d1

How to cite

Metabolic reprogramming and cisplatin resistance: the emerging role of Pyruvate Dehydrogenase Kinases (PDKs) — Europe PMC PMID:41904526 — Europe PMC (en), https://europepmc.org/article/MED/41904526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22d5083452d1 (Metraipolis archive dc_22d5083452d1, sha256 b0a05df1dee4c8d69fd83fba09cae8692ecc06fce8bd5324448890957b01e87f)
BibTeX
@misc{dc22d5083452d1,
  title = {Metabolic reprogramming and cisplatin resistance: the emerging role of Pyruvate Dehydrogenase Kinases (PDKs) — Europe PMC PMID:41904526},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41904526},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22d5083452d1; sha256 b0a05df1dee4c8d69fd83fba09cae8692ecc06fce8bd5324448890957b01e87f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904526. Agents can read the archived copy with the MCP tool read_document.